This will provide patients a far more cost-effective treatment option, and enable doctors to treat a wider patient population in the country.
Read More at:
https://health.economictimes.indiatimes.com/news/pharma/glenmark-pharma-launches-pulmonary-fibrosis-treatment-drug-in-india/78654036
